Importantly, since cell culture does not mimic all real tumour conditions, including O2 and nutrient limitation, key factors in metabolism, it is fundamental to assess the effects of MCT inhibition in vivo, evaluating aggressiveness parameters, such as tumour growth, angiogenesis and metastisation. This evidence concerns the gene SLC16A1 and neoplasm.